News
Caledonian Holdings PLC - investment company focused on financial services - Hires Keith Barclay as investment director, joining the board upon completion of due diligence. Most recently, Barclay was ...
While London South East do their best to maintain the high quality of the information displayed on this site, we cannot ...
Indigo Acquisition Corp. is listed on the CBOE trading with ticker code INACU.US. It has a market capitalisation of -, with approximately 0.00 shares in issue. Over the last year, Indigo ...
Graniteshares 2x Long Dell Daily Etf is listed on the CBOE trading with ticker code DLLL.US. It has a market capitalisation of -, with approximately 0.00 shares in issue. Over the last year ...
Ubs Core Bbg Us Treasury 10+ Ucits Etf Usd Acc is listed on the Euronext Milan trading with ticker code T10A.MI. It has a market capitalisation of -, with approximately 52.00k shares in issue.
While London South East do their best to maintain the high quality of the information displayed on this site, we cannot ...
At 14:00 PM, the FTSE 100 Index was down by -55.53 at 9077.28 points, a movement of -0.61%, showing a general fall in the market. IMI (IMI) was a well traded share, with approximately £2,011.4m ...
(Alliance News) - Melrose Industries PLC on Friday said all of its end markets were growing structurally amid rapidly increasing demand in the defence sector, as it increased its dividend amid a swing ...
The NAV total return was short of the 0.8% of the trust's benchmark, the FTSE all-world index. However, the company's share price total return matched it at 0.8%, as the discount of its share price to ...
is listed on the CBOE trading with ticker code ACFN.US. It has a market capitalisation of -, with approximately 0.00 shares in issue. Over the last year, ACFN.US share price has been traded in a ...
Visionwave Holdings Inc. is listed on the CBOE trading with ticker code VWAV.US. It has a market capitalisation of -, with approximately 0.00 shares in issue. Over the last year, Visionwave ...
In London, pharmaceutical stocks weighed on the blue-chip FTSE 100 index after Trump demanded that drug companies lower prices for American consumers. GSK fell 1.2% and AstraZeneca dipped 1.8%.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results